Kura Oncology Logo
Kura Oncology to Present at JMP Securities Life Sciences Conference
14 juin 2018 07h30 HE | Kura Oncology, Inc.
SAN DIEGO, June 14, 2018 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq:KURA), a clinical-stage biopharmaceutical company focused on the development of precision medicines for oncology, today...
OncoDNA announces screening collaboration with Kura Oncology
22 mai 2018 07h00 HE | Kura Oncology, Inc.
- OncoDNA to support patient enrolment for Kura Oncology’s Phase II trial of tipifarnib- Agreement demonstrates OncoDNA’s biopharma partnership strategy GOSSELIES, Belgium, May 22, 2018 (GLOBE...
Kura Oncology Logo
Kura Oncology Reports First Quarter 2018 Financial Results and Provides Corporate Update
08 mai 2018 16h05 HE | Kura Oncology, Inc.
– Registration-directed trial of tipifarnib in HRAS mutant head and neck squamous cell carcinomas (HNSCC) on track to initiate in second half of 2018 – – Data from multiple Phase 2 trials of...
Kura Oncology Logo
Kura Oncology to Present at Deutsche Bank 43rd Annual Health Care Conference
03 mai 2018 07h30 HE | Kura Oncology, Inc.
SAN DIEGO, May 03, 2018 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq:KURA), a clinical-stage biopharmaceutical company focused on the development of precision medicines for oncology, today...
Kura Oncology Logo
Kura Oncology Announces New Patent for Tipifarnib in Hematologic Malignancies
02 mai 2018 07h30 HE | Kura Oncology, Inc.
– Newly issued patent expands protection for tipifarnib in U.S., provides exclusivity in certain CXCL12-expressing cancers to 2037 – – Second U.S. patent for tipifarnib reinforces potential for...
Kura Oncology Logo
Kura Oncology to Report First Quarter 2018 Financial Results
01 mai 2018 07h30 HE | Kura Oncology, Inc.
SAN DIEGO, May 01, 2018 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq:KURA), a clinical-stage biopharmaceutical company focused on the development of precision medicines for oncology, today...
Kura Oncology Logo
Kura Oncology Announces Upcoming Presentations at AACR Annual Meeting 2018
09 avr. 2018 07h30 HE | Kura Oncology, Inc.
SAN DIEGO, April 09, 2018 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq:KURA), a clinical-stage biopharmaceutical company focused on the development of precision medicines for oncology, today...
Kura Oncology Logo
Kura Oncology Provides Regulatory Update on Tipifarnib and Reports Fourth Quarter and Full Year 2017 Financial Results
12 mars 2018 16h05 HE | Kura Oncology, Inc.
– Company plans to initiate registration-directed trial of tipifarnib in second half of 2018 following recent end of Phase 2 meeting with the FDA – – Single-arm trial to enroll at least 59...
Kura Oncology Logo
Kura Oncology to Present at Cowen and Company 38th Annual Health Care Conference
06 mars 2018 07h30 HE | Kura Oncology, Inc.
SAN DIEGO, March 06, 2018 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq:KURA), a clinical-stage biopharmaceutical company focused on the development of precision medicines for oncology, today...
Kura Oncology Logo
Kura Oncology to Report Fourth Quarter and Full Year 2017 Financial Results
05 mars 2018 16h05 HE | Kura Oncology, Inc.
SAN DIEGO, March 05, 2018 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq:KURA), a clinical-stage biopharmaceutical company focused on the development of precision medicines for oncology, today...